Patient-specific measurement of functional movement disorders

Completed

• Conditions: Functional movement disorders; 10028037; 10077546

• Registration Number: NL-OMON46241
• Lead Sponsor: eurologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-11-14
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 43

Inclusion Criteria

- Age > 18
- Functional movement disorder, according to Fahn criteria, as judged by a neurologist
Or a neurological movement disorder, as judged by a neurologist.
- Symptom duration > 1 year
- capable of keeping an electronic diary five times a day and have acces to internet at 9.00; 12.00; 15.00; 18.00; 21.00

Exclusion Criteria

- current medical treatment with botulinum
- psychological treatment in the previous 6 months

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Contributing factors to objective (and/or) subjective symptom fluctuation in<br /><br>individual patients. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The following possible contributing factors will be studied:<br /><br>- Positive And Negative Affect Schedule (PANAS)<br /><br>- Physical activity<br /><br>- Fatigue<br /><br>- Attention (in terms of social or mental activities)<br /><br>- Personal factor<br /><br><br /><br>Furthermore, to measure the effect of the study, patient will complete<br /><br>questionnaires on self-belief (General Self-Efficacy Scale), quality of life<br /><br>(EQ-5D), and clinical global impression (CGI)</p><br>